Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B12 Trafficking.
|
26483544 |
2015 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of functional domains of the cblD (MMADHC) gene product.
|
24722857 |
2014 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism.
|
22156578 |
2012 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Gene identification for the cblD defect of vitamin B12 metabolism.
|
18385497 |
2008 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Gene identification for the cblD defect of vitamin B12 metabolism.
|
18385497 |
2008 |
Methylmalonic Aciduria and Homocystinuria, CblD Type
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Homocystinuria, CblD Type, Variant 1
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Homocystinuria, CblD Type, Variant 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Homocystinuria, CblD Type, Variant 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Dystonia
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
Dystonia
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Methylmalonic Aciduria, CblD Type, Variant 2
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Methylmalonic Aciduria, CblD Type, Variant 2
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Homocystinuria
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
The results of molecular analysis of the MMADHC gene are consistent with the hypothesis that mutations affecting the N terminus of the MMADHC protein are associated with methylmalonic aciduria, and mutations affecting the C terminus are associated with homocystinuria.
|
19058814 |
2009 |
Methylmalonic acidemia
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
The results of molecular analysis of the MMADHC gene are consistent with the hypothesis that mutations affecting the N terminus of the MMADHC protein are associated with methylmalonic aciduria, and mutations affecting the C terminus are associated with homocystinuria.
|
19058814 |
2009 |
Methylmalonic aciduria
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
The results of molecular analysis of the MMADHC gene are consistent with the hypothesis that mutations affecting the N terminus of the MMADHC protein are associated with methylmalonic aciduria, and mutations affecting the C terminus are associated with homocystinuria.
|
19058814 |
2009 |
Homocystinuria
|
0.120 |
Biomarker
|
disease |
BEFREE |
The cblD gene was localized to human chromosome 2q23.2, and a candidate gene, designated MMADHC (methylmalonic aciduria, cblD type, and homocystinuria), was identified in this region.
|
18385497 |
2008 |
Methylmalonic acidemia
|
0.120 |
Biomarker
|
phenotype |
BEFREE |
The cblD gene was localized to human chromosome 2q23.2, and a candidate gene, designated MMADHC (methylmalonic aciduria, cblD type, and homocystinuria), was identified in this region.
|
18385497 |
2008 |
Methylmalonic aciduria
|
0.120 |
Biomarker
|
disease |
BEFREE |
The cblD gene was localized to human chromosome 2q23.2, and a candidate gene, designated MMADHC (methylmalonic aciduria, cblD type, and homocystinuria), was identified in this region.
|
18385497 |
2008 |
Homocystinuria
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Methylmalonic acidemia
|
0.120 |
Biomarker
|
phenotype |
HPO |
|
|
|
Methylmalonic aciduria
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Anemia, Megaloblastic
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anorexia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|